Abstract
Hypertension is a major risk factor for stroke and many patients with acute stroke have elevated blood pressures. The management of hypertension in the setting of acute ischaemic stroke remains a source of confusion and controversy. Lowering blood pressure in this setting may be hazardous because of impaired cerebral autoregulation. Treatment may be considered in patients who are otherwise candidates for thrombolytic therapy, patients who have severe hypertension or patients who have specific concomitant medical conditions including acute myocardial infarction, aortic dissection, hypertensive encephalopathy, or severe left ventricular failure.
In choosing an agent for acute treatment, drugs that can produce a precipitous decline in blood pressure (e.g. sublingual calcium antagonists) should be avoided. Drugs with the capacity to dilate cerebral vessels should be used with caution as they have the potential to increase intracranial pressure. Long term management of hypertension in poststroke patients is often required. The potential for certain classes of drugs (e.g. α2-adrenergic receptor agonists and α1-adrenergic receptor antagonists) to impair the recovery process should be considered when choosing an antihypertensive for treatment of these patients.
Similar content being viewed by others
References
Qizilbash N, Lewington S, Duffy S, et al. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet 1995; 346: 1647–53
Kannel WB. Blood pressure as a contributor to stroke. Fed Pract 1995; 12: 14–20
Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 1993; 43: 461–7
Wilson DA. On the contribution of respiratory gases to cerebral autoregulation. AdvExp Med Biol 1997; 428: 695–702
Meyer JS, Shimazu K, Fukuuchi Y, et al. Impaired neurogenic cerebrovascular control and dysautoregulation after stroke. Stroke 1973; 4: 169–86
Paulson OB. Cerebral apoplexy. Pathogenesis, pathophysiology and therapy as illustrated by regional cerebral blood flow measurements in brain. Stroke 1971; 2: 327–60
Meyer JS, Denny-Brown D. The cerebral collateral circulation. 1. Factors influencing collateral blood flow. Neurology 1957; 7: 447–58
Baumbach GL, Heistad DD. Cerebral circulation in chronic arterial hypertension. Hypertension 1998; 12: 89–95
Britton M, De Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand 1980; 207: 253–7
Britton M, Carlsson A. Very high blood pressure in acute stroke. J Int Med 1990; 228: 611–5
Jorgensen HS, Nakayama H, Raaschou HO, et al. Effect of blood pressure and diabetes on stroke in progression. Lancet 1994; 344: 156–9
Chamorro A, Vila N, Ascaso C, et al. Blood pressure and functional recovery in acute ischemic stroke. Stroke 1998; 29: 1850–3
Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246: 2177–80
Wechsler LR, Koroshetz W. Therapy for acute ischemic stroke. In: Ropper AH, editor. Neurol Neurosurg Intensive Care. New York: Raven Press, 1993: pp 265–78
Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke 1994; 25: 1726–9
Carlberg B, Asplund K, Hagg R. Course of blood pressure in different subsets of patients after acute stroke. Cerebrovasc Dis 1991; 1: 281–7
Cummins RO. Acute stroke: advanced cardiac life support. In: Cummins RO, editor. Dallas: American Heart Association, 1997
Adams Jr HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke - a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 1996; 27: 1711–8
Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998; 29: 1504–9
Carlsson A, Britton M. Blood pressure after stroke: a one-year follow-up study. Stroke 1993; 24: 195–9
Rodgers A, MacMahon S, Gamble G, et al. Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 1996; 313: 147
Gueyffier F, Boissel JP, Boutitie F, et al. Effect of antihypertensive treatment in patients having already suffered from stroke - gathering the evidence. Stroke 1997; 28: 2557–62
Neal B, Anderson C, Chalmers J, et al. Blood pressure lowering in patients with cerebrovascular disease: results of the PROGRESS pilot phase. Clin Exp Pharmacol Physiol 1996; 23: 444–6
Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol 1998; 55: 454–6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goldstein, L.B. Should Antihypertensive Therapies be Given to Patients with Acute Ischaemic Stroke?. Drug-Safety 22, 13–18 (2000). https://doi.org/10.2165/00002018-200022010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200022010-00002